Other languages ESSA Pharma Inc.

Equities

EPIX

CA29668H7085

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
5.7 ^USD	-8.80%		-8.65%	-13.64%

Mar. 06	Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call
Mar. 06	Norway's wealth fund pushes for more women on emerging market company boards	RE

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Norway's wealth fund pushes for more women on emerging market company boards	Mar. 06
ESSA Pharma Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 13
ESSA Pharma Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	Dec. 12
Essa Pharma Insider Bought Shares Worth $133,274, According to a Recent SEC Filing	Nov. 24
Essa Pharma Insider Bought Shares Worth $419,661, According to a Recent SEC Filing	Nov. 16
ESSA Pharma Inc. Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 30th Annual Prostate Cancer Foundation Scientific Retreat	23-10-26
ESSA Pharma Files $200 Million Mixed Shelf	23-09-20
ESSA Pharma Inc. Announces Initiation of Phase 2 Study Evaluating Masofaniten (EPI-7386) in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer	23-09-18
ESSA Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-08
Essa Pharma Inc. Appoints Lauren Merendino to Its Board of Directors	23-06-06
ESSA Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-09
ESSA Pharma Signs Clinical Trial Support Deal With Janssen to Evaluate EPI-7386 Combinations to Treat Prostate Cancer	23-04-12
ESSA Pharma Inc. Announces Clinical Trial Support Agreement with Janssen Research & Development, LLC	23-04-12
BB Biotech bestätigt Verlust für 2022 - Erwartet mehr Aktivität 2023	23-02-17
ESSA Pharma Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	23-02-07
ESSA Pharma Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2022	22-12-13
ESSA Pharma Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	22-12-13
ESSA Pharma, Janssen Suspend Enrollment in Prostate Cancer Treatment Study; ESSA Pharma Shares Sink	22-10-31
ESSA Pharma Inc. Provides an Update on Its Clinical Collaboration with Janssen	22-10-31
Sector Update: Healthcare Stocks Fade but Stay in Positive Territory Wednesday	22-10-26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ESSA Pharma Inc.

Equities

EPIX

CA29668H7085

Other languages

Filters